Odile Esther Levy
29Patents
15h-index
72Co-inventors
84Inventor score
Filing activity: Jun 17, 1994 → Mar 3, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7012066B2 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | Human Necessities | 83 | Expired |
| US8263545B2 | GIP analog and hybrid polypeptides with selectable properties | Human Necessities | 57 | Active |
| US7244721B2 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | Human Necessities | 50 | Expired |
| US6800434B2 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | Human Necessities | 47 | Expired |
| US8076288B2 | Hybrid polypeptides having glucose lowering activity | Human Necessities | 44 | Active |
| US8759295B2 | Peptide-peptidase inhibitor conjugates and methods of using same | Human Necessities | 32 | Active |
| US7169760B2 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | Chemistry; Metallurgy | 24 | Expired |
| US8497240B2 | DPP-IV resistant GIP hybrid polypeptides with selectable properties | Chemistry; Metallurgy | 21 | Active |
| US6586405B2 | Non-covalent inhibitors of urokinase and blood vessel formation | Human Necessities | 19 | Expired |
| US7723471B2 | Pancreatic polypeptide family motifs, polypeptides and methods comprising the same | Human Necessities | 18 | Active |
| US5714499A | 3-amino-2-oxo-1-piperidineacetic derivatives containing an arginine mimic as enzyme inhibitors | Human Necessities | 17 | Expired |
| US5637599A | Arginine mimic derivatives as enzyme inhibitors | Human Necessities | 17 | Expired |
| US8603969B2 | Pancreatic polypeptide family motifs and polypeptides comprising the same | Human Necessities | 17 | Active |
| US8697647B2 | Hybrid polypeptides with selectable properties | Human Necessities | 16 | Active |
| US8404637B2 | GIP analog and hybrid polypeptides with selectable properties | Chemistry; Metallurgy | 15 | Expired |
| USRE43298E1 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | General | 15 | Active |
| US8426361B2 | Pancreatic polypeptide family motifs, polypeptides and methods comprising the same | Human Necessities | 14 | Active |
| US5932733A | 3-amino-2-oxo-1-piperidineacetic derivatives containing an arginine mimic as enzyme inhibitors | Chemistry; Metallurgy | 9 | Expired |
| US7019019B2 | Matriptase inhibitors and methods of use | Chemistry; Metallurgy | 4 | Expired |
| US5883107A | Arginine mimic derivatives as enzyme inhibitors | Human Necessities | 2 | Expired |
| US9593154B2 | Engineered polypeptides having enhanced duration of action | Chemistry; Metallurgy | 2 | Active |
| US6376649B1 | Methods for the synthesis of &agr;- hydroxy-&bgr;-amino acid and amide derivatives | Emerging Cross-Sectional Technologies | 2 | Expired |
| US8598314B2 | Peptide-peptidase-inhibitor conjugates and methods of making and using same | Human Necessities | 2 | Active |
| US7262211B2 | Aromatic heterocyclic non-covalent inhibitors of urokinase and blood vessel formation | Human Necessities | 0 | Expired |
| US9453063B2 | Hybrid polypeptides with selectable properties | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.